Read news on Novo Nordisk with our app.
Read more in the app
Novo Nordisk Loses Canadian Patent Protection For Blockbuster Diabetes Drug Over Unpaid $450 Fee
SAP leapfrogs Novo Nordisk to become Europe’s most valuable company
Novo Nordisk, Sanofi Face South Africa Insulin Antitrust Probe
Novo Nordisk Takes $820 Million Charge on Failed Heart Drug
FTC challenges 'junk' patents held by 10 drugmakers, incl Novo Nordisk's Ozempic
